A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
Recruiting now · Not applicable
Conditions studied: Obesity, Adolescent, Dietary Sugars, Taste Perception, Insulin Resistance, Feeding Behavior
In brief
The goal of this clinical trial is to test whether replacing sugary sodas with unsweetened, flavored sparkling waters can reduce added sugar intake and improve health in Black/African American and Latine adolescents with obesity who prefer sweet-tasting beverages. The main questions it aims to answer are: * Does replacing sugary sodas with water change liking for sugary drinks, and water? * Do shifts in liking for sweetness lead to improved diet quality and cardiometabolic health? Researchers will compare replacing sugary sodas with one of three alternative beverages: unsweetened sparkling water, plain water, and beverages with gradually reduced sugar to determine which strategy is most effective. Participants will: * Replace sugary sodas with study drinks for 4 weeks * Complete taste tests to measure their liking for and sensory experience of sweetness over 8-weeks * Provide dietary recalls, body measurements, and blood samples over 8-weeks
Key facts
- Study ID
- NCT07223151
- Run by
- Nana Gletsu Miller
- People needed
- 63
- Starts
- 2025-07-25
- Expected to finish
- 2027-06-01
- Last updated by the study team
- 2026-08-06
Who can join
Age: 12 and older, up to 18. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Adolescents ages 12 to 18 who display a "sweet-liker" pattern, characterized by a preference for higher concentrations of sugar in beverages, specifically identifying 0.3M (10.3% sucrose) or above as their most liked sample.
- Adolescents consumes sugar-sweetened soda greater than or equal to 2 times per week. Adolescents must also indicate a willingness to drink study beverages; not currently dieting/changing diet.
You may not qualify if…
- Adolescent participant is pregnant, since pregnancy affects taste perception
- Participant is allergic or intolerant to the items we are testing.
- Adolescent with type 1 or type 2 diabetes (self-declared or detected at screening visit through fasting glucose)
- Use of GLP-1 receptor agonists intended for weight loss.
Where it is running
- Indiana University Hospital — Indianapolis, Indiana, United States (enrolling)
- Purdue University — West Lafayette, Indiana, United States (enrolling)
- Indiana University School of Public Health - Bloomington — Bloomington, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.